not tagged
not tagged
['brca', 'prostate']
the biology underlying targeting both of ar and parp in prostate cancer is the synergy and synthetic lethality of these two genes. this asco presented 4 studies exploiting these mechanisms. data are very impressive, particularly for subgroups with brca 1/2 mutations.
A cancer researcher in New York. A poet by chance. A polymath by choice.